Mergers: Big Pharma Shrinks Some

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-08-01-2001
Volume 0
Issue 0

London-GlaxoSmithKline is proposing to cut more than 2,000 jobs from its worldwide workforce of 100,000 as it seeks to generate the promised savings from its merger.

Recent Videos
Arda Ural
Lynlee Brown
Arda Ural
Related Content